Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Think the medical consultants the press/media have

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155485
(Total Views: 715)
Posted On: 04/10/2020 4:44:07 PM
Posted By: DJknows
Re: Bixellou #26801
Think the medical consultants the press/media have are telling them not to do stories or ask about Leronlimab until the "human data" Dr. pourhassan mentioned yesterday is analyzed and confirmed. Otherwise I cannot understand why they are not running with it to "break the news" or for any of them to "scoop" such an important story. You see the two local television stations did it already as well as some others such as 'investor' broadcast operations (Proactive etc.) but the bigger or national media seem reluctant to do so just yet... especially the 'news' divisions.

Dr. Pourhassan said in the Proactive interview yesterday they submitted the 'human data' to the powers-that-be (FDA, NIH and whatever/whoever else) Thursday morning. Hopefully they all still continue to WORK despite this holiday weekend and maybe by early next week they'll disseminate the great 'news' about lifesaver Leronlimab with minimal if any side effects.

On another note, Dr. Pourhassan said they'll sign a new contract with Samsung Biologics Monday morning to manufacture/produce more Leronlimab viles.

And

I bet Novant Health... with 500 facilities under their care... is likely just one of the more than 70 hospitals/institutions/med centers Dr. Pourhassan stated contacted CytoDyn about Leronlimab. Just hope Samsung Biologics in S. Korea and AGC Biologics in Washington State can produce the quantities needed around the world...

Quote:
Novant Health consists of more than 1,200 physicians and 26,000 employees who make healthcare remarkable at nearly 500 locations, including 14 medical centers and hundreds of outpatient facilities and physician clinics.
Novant Health | LinkedIn





(3)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us